Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis
Abroad (travel likely)Recruiting
Conditions
EBV-associated T/NK-cell Lymphoproliferative Diseases · Refractory/Relapsed EBV-related Hemophagocytic Lymphohistiocytosis · Letermovir
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beijing Children's Hospital, Capital Medical University, Beijing, Beijing Municipality, China